drugset / Trial / NCT00511901
Prevalence and Treatment of Anemia in Rehabilitation Patients
Phase 4
Terminated
22 enrolled
University of Medicine and Dentistry of New Jersey
Ortho Biotech Clinical Affairs, L.L.C. · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Patients who are admitted to subacute rehabilitation facilities following hospitalization are frequently anemic. The purpose of this study is to see if anemic patients treated with epoetin alfa will have higher hemoglobin levels and better functional recovery at 3, 8, and 12 weeks after study entry compared to patients who do not receive epoetin alfa.
Timeline
- Start
- 2005-11
- Primary completion
- 2008-05
- Completion
- 2008-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | epoetin alfa | Protein / enzyme biologic | 40000 iu | Subcutaneous |
| Comparator | Polysaccharide iron complex | Unknown | 150 mg | — |